Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-27

Clinical Trial Update: Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy [Phase 2, Phase 3]

View source ↗

Summary

This update reports completion of a phase 2/3 trial evaluating creatine and L-glutamine in steroid-naive Duchenne muscular dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Creatine (creatine)
  • Glutamine (glutamine)

Snippet

Sponsor: Cooperative International Neuromuscular Research Group | Conditions: Muscular Dystrophy, Duchenne | Phase 2, Phase 3 | Status: COMPLETED